These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31727773)

  • 1. Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity.
    Horiguchi H; Kadomatsu T; Kurahashi R; Hara C; Miyata K; Baba M; Osumi H; Terada K; Araki K; Takai T; Kamba T; Linehan WM; Moroishi T; Oike Y
    Genes Dev; 2019 Dec; 33(23-24):1641-1656. PubMed ID: 31727773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
    Horiguchi H; Kadomatsu T; Yamashita T; Yumoto S; Horino T; Sato M; Terada K; Miyata K; Ichigozaki Y; Kimura T; Fukushima S; Moroishi T; Oike Y
    Cancer Gene Ther; 2024 Jun; 31(6):933-940. PubMed ID: 38467764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANGPTL2-mediated epigenetic repression of MHC-I in tumor cells accelerates tumor immune evasion.
    Kadomatsu T; Hara C; Kurahashi R; Horiguchi H; Morinaga J; Miyata K; Kurano S; Kanemaru H; Fukushima S; Araki K; Baba M; Linehan WM; Kamba T; Oike Y
    Mol Oncol; 2023 Dec; 17(12):2637-2658. PubMed ID: 37452654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroma-derived ANGPTL2 establishes an anti-tumor microenvironment during intestinal tumorigenesis.
    Horiguchi H; Kadomatsu T; Miyata K; Terada K; Sato M; Torigoe D; Morinaga J; Moroishi T; Oike Y
    Oncogene; 2021 Jan; 40(1):55-67. PubMed ID: 33051596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Angiopoietin-Like Protein 2 Inhibits Proliferation and Invasion in Glioma Cells via Suppressing the ERK/MAPK Signaling Pathway.
    Yang LK; Zhu J; Chen YH; Wang DL; Li H; Zhang LJ; Zhou JR; Liu W
    Oncol Res; 2017 Sep; 25(8):1349-1355. PubMed ID: 28247845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells.
    Osumi H; Horiguchi H; Kadomatsu T; Tashiro K; Morinaga J; Takahashi T; Ikeda K; Ito T; Suzuki M; Endo M; Oike Y
    Cancer Sci; 2020 Apr; 111(4):1241-1253. PubMed ID: 32012400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angptl2 deficiency attenuates paraquat (PQ)-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis through NF-κB pathway.
    Yang W; Liu W; Yu W; Fei D; Meng X; Yang S; Meng S; Zhao M
    Biochem Biophys Res Commun; 2018 Sep; 503(1):94-101. PubMed ID: 29852175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-Like Protein 2 Promotes the Progression of Diabetic Kidney Disease.
    Ishii T; Furuya F; Takahashi K; Shikata M; Takamura T; Kobayashi H; Miyazaki A; Morinaga J; Terada K; Oike Y; Kanda E; Kitamura K
    J Clin Endocrinol Metab; 2019 Jan; 104(1):172-180. PubMed ID: 30137449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice.
    Caland L; Labbé P; Mamarbachi M; Villeneuve L; Ferbeyre G; Noly PE; Carrier M; Thorin-Trescases N; Thorin É
    Aging (Albany NY); 2019 Jun; 11(11):3832-3850. PubMed ID: 31186381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance.
    Takeshita Y; Motohara T; Kadomatsu T; Doi T; Obayashi K; Oike Y; Katabuchi H; Endo M
    Biochem Biophys Res Commun; 2021 Jul; 561():26-32. PubMed ID: 34000514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like protein 2 is a positive regulator of osteoblast differentiation.
    Takano A; Fukuda T; Shinjo T; Iwashita M; Matsuzaki E; Yamamichi K; Takeshita M; Sanui T; Nishimura F
    Metabolism; 2017 Apr; 69():157-170. PubMed ID: 28285646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANGPTL2 deletion inhibits osteoclast generation by modulating NF-κB/MAPKs/Cyclin pathways.
    Li WM; Han CL; Liu C; Xing HY; Ding DC
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1471-1477. PubMed ID: 30031603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-like protein 2 renders colorectal cancer cells resistant to chemotherapy by activating spleen tyrosine kinase-phosphoinositide 3-kinase-dependent anti-apoptotic signaling.
    Horiguchi H; Endo M; Miyamoto Y; Sakamoto Y; Odagiri H; Masuda T; Kadomatsu T; Tanoue H; Motokawa I; Terada K; Morioka MS; Manabe I; Baba H; Oike Y
    Cancer Sci; 2014 Dec; 105(12):1550-9. PubMed ID: 25287946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesis.
    Horiguchi H; Kadomatsu T; Yumoto S; Masuda T; Miyata K; Yamamura S; Sato M; Morinaga J; Ohtsuki S; Baba H; Moroishi T; Oike Y
    Oncogene; 2022 Aug; 41(33):4028-4041. PubMed ID: 35831580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity.
    Yugami M; Odagiri H; Endo M; Tsutsuki H; Fujii S; Kadomatsu T; Masuda T; Miyata K; Terada K; Tanoue H; Ito H; Morinaga J; Horiguchi H; Sugizaki T; Akaike T; Gotoh T; Takai T; Sawa T; Mizuta H; Oike Y
    J Biol Chem; 2016 Sep; 291(36):18843-52. PubMed ID: 27402837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis.
    Endo M; Yamamoto Y; Nakano M; Masuda T; Odagiri H; Horiguchi H; Miyata K; Kadomatsu T; Motokawa I; Okada S; Iwase H; Oike Y
    Int J Biol Markers; 2014 Sep; 29(3):e239-45. PubMed ID: 24585434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
    Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.
    Zhou J; Wang J; Wu S; Zhu S; Wang S; Zhou H; Tian X; Tang N; Nie S
    Int J Mol Med; 2014 Nov; 34(5):1286-92. PubMed ID: 25174582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
    Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
    Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.